| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/13/2013 | CN102048159B Camellia oil microcapsule powder and preparation method thereof |
| 02/13/2013 | CN101805784B Single nucleotide polymorphism of human WNK4 genes and application thereof |
| 02/13/2013 | CN101721468B Method for preparing salvianolic acids |
| 02/13/2013 | CN101721466B Quality control method for salvianolic acid injection |
| 02/13/2013 | CN101712676B Water soluble puerarin derivatives and preparation method and application thereof |
| 02/13/2013 | CN101490035B Amino-piperidine derivatives as CETP inhibitors |
| 02/13/2013 | CN101098689B Pharmaceutical combinations of an angiotensin receptor antagonist and an nep inhibitor |
| 02/13/2013 | CN101015353B Pure natural oxygenation health care beverage and compounding process thereof |
| 02/12/2013 | US8372990 Bicyclic tetrahydropyrrole compounds |
| 02/12/2013 | US8372984 Dual-acting oxazole antihypertensive agents |
| 02/12/2013 | US8372981 Nitrogen-containing aromatic derivatives |
| 02/12/2013 | US8372978 Salts of methyl 2-((R)-(3-chlorophenyl)((R)-1-((S)-2-(methylamino)-3-((R)-tetrahydro-2H-pyran-3-yl)propylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate |
| 02/12/2013 | US8372809 Method of treating dyspnea associated with acute heart failure |
| 02/12/2013 | US8372404 Anti-C5/C5a antibodies and methods of use |
| 02/12/2013 | US8372401 Human antibodies that bind human TNFα |
| 02/12/2013 | US8372400 Methods of treating disorders using human antibodies that bind human TNFα |
| 02/12/2013 | CA2429817C Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| 02/12/2013 | CA2382303C Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 02/12/2013 | CA2336250C Anti-ccr2 antibodies and methods of use therefor |
| 02/10/2013 | CA2755715A1 Antihypertensive agents |
| 02/07/2013 | WO2013020132A1 Methods of treating cardiovascular and metabolic diseases |
| 02/07/2013 | WO2013019805A1 Treatment of heart failure and related conditions |
| 02/07/2013 | WO2013019169A1 Phosphate prodrugs |
| 02/07/2013 | WO2013019091A2 A COMPOUND FOR INHIBITING 11β-HYDROXY STEROID DEHYDROGENASE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME |
| 02/07/2013 | WO2013018899A1 Dibenzooxepin derivative |
| 02/07/2013 | WO2013018837A1 Left ventricular diastolic function improving agent |
| 02/07/2013 | WO2013018804A1 Uracil derivative and use thereof for medical purposes |
| 02/07/2013 | WO2013018779A1 CRYSTAL OF α-GLUCOSYL HESPERIDIN AND USE THEREOF |
| 02/07/2013 | WO2013018733A1 1,5-naphthyridine derivative or salt thereof |
| 02/07/2013 | WO2013018695A1 Heterocyclic compound |
| 02/07/2013 | WO2013018008A1 Basic alpha lipoic acid solution and its uses |
| 02/07/2013 | WO2013017071A1 Alicyclic[c] benzopyrone derivatives and uses thereof |
| 02/07/2013 | WO2013017068A1 Substituted benzopyrone derivative and use thereof |
| 02/07/2013 | US20130035755 Medical device with coating that promotes endothelial cell adherence |
| 02/07/2013 | US20130035754 Drug-delivery endovascular stent and method of forming the same |
| 02/07/2013 | US20130035392 Selective inhibition of the membrane attack complex of complement and C3 convertase by low molecular weight components of the aurin tricarboxylic acid synthetic complex |
| 02/07/2013 | US20130035388 Selective inhibition of the membrane attack complex of complement by low molecular weight components of the aurin tricarboxylic acid synthetic complex |
| 02/07/2013 | US20130035368 Oligonucleotide compounds comprising non-nucleotide overhangs |
| 02/07/2013 | US20130035364 Benzylidene-indolinone compounds and their medical use |
| 02/07/2013 | US20130035358 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 02/07/2013 | US20130035356 Crystal of diamine derivative and method of producing same |
| 02/07/2013 | US20130035354 Aryl pyridine as aldosterone synthase inhibitors |
| 02/07/2013 | US20130035347 Aromatic bycyclic derivatives as cxcr4 receptor modulators |
| 02/07/2013 | US20130035346 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 02/07/2013 | US20130035345 Solid dispersion formulations and methods of use thereof |
| 02/07/2013 | US20130035344 Pharmaceutical composition for oral administration |
| 02/07/2013 | US20130035339 Apoptosis signal-regulating kinase inhibitors |
| 02/07/2013 | US20130035337 Fused bicyclic heteroaryl derivative |
| 02/07/2013 | US20130035324 Heterocyclic compounds and uses thereof |
| 02/07/2013 | US20130035316 Pharmaceutical composition comprising metformin and rosuvastatin |
| 02/07/2013 | US20130035311 Prochelators for inhibiting metal-promoted oxidative stress |
| 02/07/2013 | US20130035310 Piperidine and Piperazine Phenyl Sulfonamides as Modulators of Ion Channels |
| 02/07/2013 | US20130035291 Obtainment of bioactive products from cocoa having inhibitory activity against the pep enzyme and antioxidant and/or antineurodegenerative activity |
| 02/07/2013 | US20130035289 Pharmaceutical composition for treatment of thrombosis-related diseases comprising a fragment of prolactin (prl)-growth hormone (gh)-placental lactogen (pl)-family protein |
| 02/07/2013 | US20130035286 Pharmaceutical Composition Comprising Cyclic Somatostatin Analogues |
| 02/07/2013 | US20130035282 Metabolic and cardioprotection by the myokine follistatin-like 1 polypeptide |
| 02/07/2013 | US20130035281 Pharmaceutical composition, methods for treating and uses thereof |
| 02/07/2013 | US20130034606 Immediate release tablet formulations |
| 02/07/2013 | US20130034599 Synthetic nanostructures including nucleic acids and/or other entities |
| 02/07/2013 | US20130034598 Inhibitors of akt/pkb with anti-tumor activity |
| 02/07/2013 | US20130034597 Orally bioavailable peptide drug compositions and methods thereof |
| 02/07/2013 | US20130034569 Il-18 receptor antigen binding proteins |
| 02/07/2013 | US20130034568 Methods of treating or preventing periodontitis and diseases associated with periodontitis |
| 02/07/2013 | US20130034553 Fusion Polypeptides Capable of Activating Receptors |
| 02/07/2013 | US20130034543 Modulating xrn1 |
| 02/07/2013 | US20130034535 Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (cvd) and diabetics |
| 02/07/2013 | US20130034495 Isotopologues of 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol |
| 02/07/2013 | US20130034493 Methods and compositions for modulation of olfml3 mediated angiogenesis |
| 02/07/2013 | CA2843836A1 Uracil derivative and use thereof for medical purposes |
| 02/07/2013 | CA2843535A1 Treatment of heart failure and related conditions |
| 02/07/2013 | CA2842906A1 Left ventricular diastolic function improving agent |
| 02/06/2013 | EP2554546A1 Pyripyropene derivative having acat2 inhibiting activity and stable to metabolizing enzymes |
| 02/06/2013 | EP2554542A1 Phenylalanine derivative salt crystal |
| 02/06/2013 | EP2554175A1 Composition for treatment of damaged part |
| 02/06/2013 | EP2552932A1 Adenosine compounds and their use thereof |
| 02/06/2013 | EP2552470A2 Peptides for promoting angiogenesis and an use thereof |
| 02/06/2013 | EP2552463A1 Proangiogenic compositions, method for preparing same, and uses thereof |
| 02/06/2013 | EP2552462A2 Ccn3 peptides and analogs thereof for therapeutic use |
| 02/06/2013 | EP2552461A1 The therapeutic use of tetrathiomolybdate |
| 02/06/2013 | EP2552454A1 ANTAGONISTS OF miRNA-29 EXPRESSION AND THEIR USE IN THE PREVENTION AND TREATMENT OF AORTIC ANEURYSMS |
| 02/06/2013 | CN102918050A Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport |
| 02/06/2013 | CN102918021A Nicotinic receptor non-competitive antagonists |
| 02/06/2013 | CN102917726A Interferon analogs |
| 02/06/2013 | CN102917723A Soybean protein hydrolysate-containing antioxidant and use thereof |
| 02/06/2013 | CN102917713A Proangiogenic compositions, method for preparing same, and uses thereof |
| 02/06/2013 | CN102917703A Novel EP4 agonist |
| 02/06/2013 | CN102917702A Zinc-containing compositions for the treatment of diseases, illnesses and syndromes associated with exposure to pore forming toxins |
| 02/06/2013 | CN102911987A Cells of which genome is modified |
| 02/06/2013 | CN102911260A Antagonists against interaction of PF4 and RANTES |
| 02/06/2013 | CN102911179A Lcotinib hydrochloride crystal form, medicinal composition and application |
| 02/06/2013 | CN102911163A Quinazoline derivatives, composition containing derivatives and pharmaceutical application of derivatives |
| 02/06/2013 | CN102908707A Hui medicine oxygen mask and matched medical oxygen medicated pad as well as preparation method of medicated pad |
| 02/06/2013 | CN102908604A Bighead atractylodes rhizome and gastrodia tuer capsules |
| 02/06/2013 | CN102908599A Medicine capable of reducing blood sugar, blood fat and blood pressure |
| 02/06/2013 | CN102908589A Composite medicament for treating diabetic feet and preparation method thereof |
| 02/06/2013 | CN102908583A Traditional Chinese medicine composition for treating chest stuffiness and pains as well as preparation method, quality detection method and application of composition |
| 02/06/2013 | CN102908546A Traditional Chinese medicine composition for treating hypertension |
| 02/06/2013 | CN102908544A Traditional Chinese medicine decoction for treating coronary disease and preparation method thereof |
| 02/06/2013 | CN102908538A Extraction method of corn stigma total flavonoids |
| 02/06/2013 | CN102908532A Traditional Chinese medicine for treating thromboangiitis |